gastroesophageal cancer

Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says
MedPage Today
Tue, 09/24/24 - 09:54 pm
FDA
ODAC
gastroesophageal cancer
PD-L1
ESMO: Jazz HER2 bispecific posts 59% survival at 30 months in gastric cancer
Fierce Biotech
Mon, 09/16/24 - 09:50 am
Jazz Pharma
zanidatamab
gastroesophageal cancer
ESMO
ALX Oncology’s evorpacept shows potential in Phase II gastric cancer trial
Clinical Trials Arena
Thu, 08/1/24 - 11:12 am
ALX Oncology
clinical trials
gastroesophageal cancer
evorpacept
Bristol Myers' Opdivo leads the pack with FDA approval for resected esophageal or GEJ cancer
Endpoints
Fri, 05/21/21 - 11:48 am
Bristol Myers Squibb
Opdivo
FDA
esophageal cancer
gastroesophageal cancer
FDA grants priority review to KEYTRUDA for treatment of esophageal and gastroesophageal junction cancer
Pharmaceutical Business Review
Fri, 12/18/20 - 10:50 am
Merck
Keytruda
FDA
esophageal cancer
gastroesophageal cancer
Astellas furthers oncology focus with Ganymed buy
BioPharma Dive
Fri, 10/28/16 - 05:48 pm
Astellas
oncology
Ganymed
M&A
IMAB362
gastroesophageal cancer
Merrimack Progresses with MM-111
Yahoo/Zacks
Sat, 07/27/13 - 11:13 am
Merrimack Pharmaceuticals
cancer
gastric cancer
esophageal cancer
gastroesophageal cancer